Current Molecular Pharmacology (CMP), a peer-reviewed international journal dedicated to publishing cutting-edge advances in cellular and molecular pharmacology, is proud to announce a major ...

Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...

The "Selecting the Best Scientific Journal for Your Research Training Course (Apr 13, 2026)" training has been added to ResearchAndMarkets.com's offering. This session offers a detailed guide to ...

The first patient received dosing at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.

Pfizer has received a tax demand order amounting to Rs 8.79 crore, including penalty, from the Office of the Additional ...

Despite price ceilings imposed on essential medicines to protect patients, pharmaceutical companies across India have ...

The National Medical Commission has approved additional seats for postgraduate programmes for the ongoing counselling process ...

Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts ...

A controversial Centers for Disease Control and Prevention panel is gearing up to review the "safety" of a common additive ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 ...

Researchers have investigated the role that estrogen plays in signaling more gut pain, and it isn't working alone.

Increasing the levels of a particular phospholipid in the membranes of brain cells may offer a promising new way to improve blood circulation in the brain and support healthier brain activity. A poten ...